Lilly to Present at Cowen Health Care Conference

INDIANAPOLIS, Feb. 24, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will present at the 35th Annual Cowen and Company Health Care Conference on Tuesday, March 3, 2015. Mr. David Ricks, Sr. Vice President and President, Lilly Bio-Medicines will speak at 10:40 a.m. EST.

A live audio webcast will be available on the Webcasts & Presentations section of Lilly's Investor website at http://investor.lilly.com/events.cfm. Subsequently, a replay of the presentation with Mr. Ricks will be available on this same website for approximately 90 days.

About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and http://newsroom.lilly.com/social-channels.  F-LLY   

Refer to:

(317) 277-6524; [email protected]; Lauren Zierke (Media)


(317) 655-6874; [email protected]; Phil Johnson (Investor)

 

Eli Lilly and Company logo.

Logo - http://photos.prnewswire.com/prnh/20031219/LLYLOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/lilly-to-present-at-cowen-health-care-conference-300040486.html

SOURCE Eli Lilly and Company

Suggested Articles

Which rollouts might suffer most? Those that treat chronic diseases, require doctors to administer them or face current competition, analysts say.

Novartis and Incyte will put their blockbuster JAK inhibitor into phase 3 clinical trials as a possible treatment for COVID-19, the drugmakers said.

The Cannes Lions canceled its advertising creativity conference for 2020 after media reports that many large ad agencies planned to opt out.